Kimberly-Clark and Kenvue: Two Giant Partnerships

Kimberly-Clark Corporation (NASDAQ:KMB) has recently been highlighted as one of the important stocks by Jim Cramer. Cramer also emphasized these shares following the announcement that the company would acquire Kenvue, a personal and household products manufacturer, for $48.7 billion.

Cramer evaluated the company's CEO and the rationale behind this acquisition, stating, "I love this deal. Because I think Kenvue is weak in areas where Kimberly-Clark is strong; especially in China. In Europe, it’s the exact opposite. Kimberly-Clark has a strong understanding of the data, and Tylenol has shown no weakness with any of the issues the government has discussed. Moreover, I must note that lawsuits regarding pregnant women have not been very impactful in Europe due to the spin-off from Johnson & Johnson. There, the penal laws are not that strict and large damages are not being sought. This situation reflects poorly on the deal, but actually, it’s not that bad."

While viewing Kimberly-Clark's potential as an investment opportunity, we believe that some artificial intelligence stocks promise higher returns. If you are looking for an extremely cheap artificial intelligence stock and would like to discover one that will greatly benefit from Trump tariffs and domestic production, you can find more information.